Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.2K
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting and directing pathology foundation models.

bioRxiv : the preprint server for biology·2026
Same author

DeSpotX: Identifiability-Based Decontamination for Spatial Transcriptomics.

bioRxiv : the preprint server for biology·2026
Same author

Non-invasive profiling of the tumour microenvironment with spatial ecotypes.

Nature·2026
Same author

Transparency of medical artificial intelligence systems.

Nature reviews bioengineering·2026
Same author

A common 19 bp APOE enhancer deletion is protective against Alzheimer's disease in African Americans.

Nature communications·2026
Same author

Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting metastatic tolerance.

Cancer cell·2026

Related Experiment Video

Updated: Mar 21, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K

Identifying Network Perturbation in Cancer.

Maxim Grechkin1, Benjamin A Logsdon2, Andrew J Gentles3

  • 1Department of Computer Science & Engineering, University of Washington, Seattle, Washington, United States of America.

Plos Computational Biology
|May 5, 2016
PubMed
Summary
This summary is machine-generated.

DISCERN identifies gene regulatory network changes between disease and normal states. This computational framework accurately pinpoints perturbed genes and potential disease mechanisms in cancer.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Experiment Videos

Last Updated: Mar 21, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Area of Science:

  • Computational biology
  • Systems biology
  • Genomics

Background:

  • Gene regulatory networks (GRNs) are crucial for understanding biological processes.
  • Identifying dynamic changes in GRNs between distinct biological states, such as disease versus normal, is challenging.

Purpose of the Study:

  • To develop a computational framework, DISCERN (DIfferential SparsE Regulatory Network), for identifying topological changes in GRNs.
  • To accurately detect perturbed genes and uncover underlying mechanisms in disease states using gene expression data.

Main Methods:

  • DISCERN infers conditional dependencies between candidate regulators and genes, improving accuracy over pairwise correlation.
  • A likelihood-based scoring function is employed to enhance the accuracy of inferred network edges.
  • The framework compares gene expression datasets from diseased and normal tissues to identify differential network structures.

Main Results:

  • DISCERN demonstrated higher accuracy in identifying perturbed genes on synthetic data compared to existing methods.
  • In acute myeloid leukemia, breast cancer, and lung cancer datasets, high-scoring genes were enriched for known tumor drivers and disease-associated processes.
  • DISCERN explained observed epigenomic activity patterns more accurately than alternative methods.

Conclusions:

  • DISCERN provides a robust computational approach for identifying differential gene regulatory networks.
  • The framework accurately identifies disease-perturbed genes and offers insights into disease mechanisms.
  • DISCERN has potential applications in understanding cancer biology and patient prognosis.